Proteasome dysregulation in human cancer: implications for clinical therapies.
about
Proteasome dysregulation in human cancer: implications for clinical therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Proteasome dysregulation in human cancer: implications for clinical therapies.
@en
Proteasome dysregulation in human cancer: implications for clinical therapies.
@nl
type
label
Proteasome dysregulation in human cancer: implications for clinical therapies.
@en
Proteasome dysregulation in human cancer: implications for clinical therapies.
@nl
prefLabel
Proteasome dysregulation in human cancer: implications for clinical therapies.
@en
Proteasome dysregulation in human cancer: implications for clinical therapies.
@nl
P2093
P2860
P1476
Proteasome dysregulation in human cancer: implications for clinical therapies.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10555-017-9704-Y
P577
2017-10-16T00:00:00Z